Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054067 · ClinicalTrials.gov registry record · Phase 3
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
A Phase 3 study, sponsored by Gynecologic Oncology Group.
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00054067 is a Phase 3 study that was terminated before completion, run by Gynecologic Oncology Group.
The verdict
NCT00054067, a Phase 3 study, was terminated before completion, sponsored by Gynecologic Oncology Group.
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy combined with chemotherapy, with or without surgery, is more effective in treating early cancer of the cervix. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery followed by different regimens of radiation therapy and chemotherapy with that of chemotherapy and radiation therapy alone in treating patients who have stage I cancer of the cervix.
Interventions
- DRUG cisplatin
- PROCEDURE conventional surgery
- RADIATION radiation therapy
- RADIATION brachytherapy
- PROCEDURE adjuvant therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054067
The ClinicalTrials.gov registry entry for NCT00054067 describes a study currently listed as terminated, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00054067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054067 about?
NCT00054067 is a clinical study titled "Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy combined with chemotherapy, with or without surgery, is more...
What is the current status of trial NCT00054067?
This trial is currently terminated. It is a Phase 3 study. The study started on 2003-02.
What interventions are being tested in trial NCT00054067?
The interventions under investigation include: cisplatin (DRUG), conventional surgery (PROCEDURE), radiation therapy (RADIATION), brachytherapy (RADIATION), adjuvant therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00054067?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.